PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24223N0086Modification decrease — Ino Therapeutics LLC

Ino Therapeutics LLC holds $2.5M across 84 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards under parent 36C24223A0002. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Sep 30, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

242-Network Contract Office 02 (36C242)

Awarding office

Ino Therapeutics LLC

Recipient

Sep 30, 2023

PoP end

$149K

Obligated

$149K

Potential

325412

NAICS

6505

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number36C24223N0086

Also listed as36C242-23-N-0086

Also listed as36C24223A0002-36C24223N0086

Agency242-Network Contract Office 02 (36C242)

Awarding office242-Network Contract Office 02 (36C242)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentIno Therapeutics LLC

CAGE1PVS3

UEIXXQHL619FUN6

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C24223A0002

Place of performanceHAZELWOOD MO

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startOct 1, 2022

PoP end (current)Sep 30, 2023

PoP end (w/ options)Sep 30, 2027

Obligated$149K

Current value$149K

Potential value$149K

Modification Decrease is a federal Unrestricted award for 242-Network Contract Office 02 (36C242) held by Ino Therapeutics LLC. Estimated value $149K ($149K obligated). Current period of performance ends Sep 30, 2023 (potential Sep 30, 2027). Last award drew 1 bidder. Place of performance: HAZELWOOD MO.

Modification decrease. Latest action is a modification.

Recompete timing

Public

● Past PoP end (1117 days ago)

Current PoP ended Sep 30, 2023 (1117 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Want the durability read on 36C24223N0086? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ino Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($2.5M) · all agencies

Department of Defense (DOD)$1.9M · 76%Department of Veterans Affairs (VA)$654K · 26%

Open full company profile →

Related awards

Same parent · incumbent

W81K0026FA029

INHALED NITRIC OXIDE

$158K

Dec 31, 2026

75N90024F00080

INO THERAPEUTICS INC:1107599 [26-001138]

$115K

Feb 28, 2027

36C24723F0049

INO THERAPUETIC

$252K

Sep 30, 2027

36C24623C0012

NITRIC OXIDE GAS

$410K

Dec 31, 2027

HT940623F0133

INHALED NITRIC OXIDE (INO) THERAPY

$482K

Sep 30, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24223N0086?

36C24223N0086 (Modification decrease) is a 242-Network Contract Office 02 (36C242) award with a potential value of $149K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-23-N-0086?

36C242-23-N-0086 is the dashed form of PIID 36C24223N0086 (Modification decrease), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24223N0086?

242-Network Contract Office 02 (36C242) awarded 36C24223N0086 to Ino Therapeutics LLC (potential $149K).

Who is the incumbent on 36C24223N0086?

Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2023.

When does Ino Therapeutics LLC’s 36C24223N0086 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24223N0086? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Oct 1, 2022